pirmenol has been researched along with Coronary Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hammill, SC; Pritchett, EL; Shand, DG; Stargel, WW; Wagner, GS | 1 |
Hastings, SG; Kaplan, HR; Mertz, TE; Potoczak, RE; Steffe, TJ | 1 |
Frick, MH; Manninen, V; Nieminen, MS; Toivonen, LK | 2 |
Morris, KG; Phillips, HR | 1 |
Easley, AR; Luck, JC; Magro, SA; Mann, DE; Reiter, MJ; Sakun, V; Sullivan, SM; Wyndham, CR | 1 |
1 review(s) available for pirmenol and Coronary Disease
Article | Year |
---|---|
Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Kinetics; Lidocaine; Myocardial Infarction; Piperidines; Propranolol | 1982 |
2 trial(s) available for pirmenol and Coronary Disease
Article | Year |
---|---|
Antiarrhythmic efficacy of pirmenol in the treatment of premature ventricular complexes.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Electrocardiography; Female; Humans; Kinetics; Male; Myocarditis; Piperidines; Tachycardia | 1985 |
Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
Topics: Adult; Analysis of Variance; Anti-Arrhythmia Agents; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Hemodynamics; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Piperidines | 1986 |
3 other study(ies) available for pirmenol and Coronary Disease
Article | Year |
---|---|
CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
Topics: Aconitine; Action Potentials; Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Epinephrine; Female; Heart Conduction System; Hemodynamics; Male; Ouabain; Piperidines; Time Factors; Ventricular Fibrillation | 1980 |
Hemodynamic effects of intravenous pirmenol.
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Coronary Disease; Depression, Chemical; Drug Evaluation; Female; Heart Ventricles; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Piperidines; Stroke Volume; Time Factors | 1988 |
Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Disease; Heart Conduction System; Humans; Male; Middle Aged; Piperidines; Tachycardia | 1986 |